|
CLN5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61020086153485E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75469971885889E-10 |
| Normal-vs-Stage2 |
2.65840000002182E-06 |
| Normal-vs-Stage3 |
1.61340052429182E-10 |
| Normal-vs-Stage4 |
1.08850000002381E-06 |
| Stage1-vs-Stage2 |
9.097800E-01 |
| Stage1-vs-Stage3 |
1.515770E-01 |
| Stage1-vs-Stage4 |
5.707200E-01 |
| Stage2-vs-Stage3 |
1.744380E-01 |
| Stage2-vs-Stage4 |
4.881200E-01 |
| Stage3-vs-Stage4 |
6.660000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.89559520594685E-12 |
| Normal-vs-AfricanAmerican |
4.68109999651745E-08 |
| Normal-vs-Asian |
5.51519999999472E-05 |
| Caucasian-vs-AfricanAmerican |
7.599200E-01 |
| Caucasian-vs-Asian |
3.662800E-01 |
| AfricanAmerican-vs-Asian |
4.363800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6698864513387E-12 |
| Normal-vs-Female |
6.65730000015685E-08 |
| Male-vs-Female |
2.568800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.11749967454966E-10 |
| Normal-vs-Extreme_Weight |
2.6988999923816E-09 |
| Normal-vs-Obese |
7.20290005418178E-09 |
| Normal-vs-Extreme_Obese |
4.239400E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.222600E-01 |
| Normal_Weight-vs-Obese |
4.149200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.830800E-01 |
| Extreme_Weight-vs-Obese |
8.357400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.288800E-01 |
| Obese-vs-Extreme_Obese |
6.987400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.23620044493123E-11 |
| Normal-vs-Age(41-60Yrs) |
1.84579995732292E-09 |
| Normal-vs-Age(61-80Yrs) |
8.35770341822695E-11 |
| Normal-vs-Age(81-100Yrs) |
5.29910000324207E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.169900E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.077000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.051600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.190400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.785900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.919600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62625468647093E-12 |
| Normal-VS-Type2 PRCC |
3.18839999957632E-08 |
| Normal-VS-KIRP CIMP |
4.47280001925066E-09 |
| Normal-VS-Unclassified PRCC |
1.29830000084041E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.537800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.893890E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.436600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.721300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.997600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.957690E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.37274652650876E-12 |
| Normal-vs-N1 |
8.60119753198774E-11 |
| Normal-vs-N2 |
8.3381000000049E-05 |
| N0-vs-N1 |
4.714400E-01 |
| N0-vs-N2 |
4.779800E-01 |
| N1-vs-N2 |
6.856000E-01 |
|
|
